Maybe I am confused but does make sense. Celgene and nimbus enter an arrangement back in 2013 to develop nimbus tyk. Last week announcement that Celgene being bought and posters ascribing value to deal because of tyk ie mentioned early in news release. But now you say nimbus realise that development was a bum flush and no milestone payments will be received and their tyk will be effectively shelved. So have nimbus their own tyk which has nothing to do with nimbus ?
Hilarious Thoth
One day you ascribe value of deal to tyk next you are saying that tyk of Celgene has no legs! So the Celgene tyk underpins the value of take over or it does not. You can’t have it both ways ?
RE: J P Morgan 2019 - San Francisco7 Jan 2019 01:31
Where Thoth?
If you read release it’s half way down and under near term launch opportunities and it’s 1 of 6 near term launch opportunities with total revenue potential 15m and it’s mentioned just once. I prefer to read statements from companies actually involved in the deal
RE: J P Morgan 2019 - San Francisco6 Jan 2019 23:00
Ahfam
Celgene is worth billions anyway. Stop trying to attribute the value of takeover to Celgene tyk because it was NOT. It’s starting to peethed me now that so many people here are adding 1 plus 1 and getting 3. The relevance of tyk to the Celgene is not high.
It does not matter what they tweet. I have invested 10k not in some Facebook Instagram tweet friendship but in a public listed company . FFS I’m not a teenager I’m a middle aged investor who wants a return on capital invested
Yep I would not work for shares only. Sar is on the right path obviously but we just need to not completely by chickens yet.
Yesterday very strange day, today’s drop even stranger
RE: Realistic AGM statement I think19 Dec 2018 08:40
Disagree jolly , reality is no one knows anything here it’s all guess work and optimism . I would say no one thought that in dec sar would be 10%-20% below a discounted placing price !
Not good